NO180233C - Derivater av 3-aminopyridaziner som virker på sentralnervesystemet, samt farmasöytiske preparater som inneholder dem - Google Patents
Derivater av 3-aminopyridaziner som virker på sentralnervesystemet, samt farmasöytiske preparater som inneholder demInfo
- Publication number
- NO180233C NO180233C NO921949A NO921949A NO180233C NO 180233 C NO180233 C NO 180233C NO 921949 A NO921949 A NO 921949A NO 921949 A NO921949 A NO 921949A NO 180233 C NO180233 C NO 180233C
- Authority
- NO
- Norway
- Prior art keywords
- image
- well
- nervous system
- central nervous
- aminopyridazines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/20—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9105973A FR2676444B1 (fr) | 1991-05-16 | 1991-05-16 | Nouveaux derives d'amino-3 pyridazines actifs sur le systeme nerveux central, procede de preparation et compositions pharmaceutiques en contenant. |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO921949D0 NO921949D0 (no) | 1992-05-15 |
| NO921949L NO921949L (no) | 1992-11-17 |
| NO180233B NO180233B (no) | 1996-12-02 |
| NO180233C true NO180233C (no) | 1997-03-12 |
Family
ID=9412856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO921949A NO180233C (no) | 1991-05-16 | 1992-05-15 | Derivater av 3-aminopyridaziner som virker på sentralnervesystemet, samt farmasöytiske preparater som inneholder dem |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US5276036A (pt) |
| EP (1) | EP0514277B1 (pt) |
| JP (1) | JPH0673021A (pt) |
| KR (1) | KR920021517A (pt) |
| AT (1) | ATE115569T1 (pt) |
| AU (1) | AU656770B2 (pt) |
| BR (1) | BR9201854A (pt) |
| CA (1) | CA2068770A1 (pt) |
| CZ (1) | CZ282531B6 (pt) |
| DE (1) | DE69200895T2 (pt) |
| DK (1) | DK0514277T3 (pt) |
| ES (1) | ES2065755T3 (pt) |
| FI (1) | FI922235A (pt) |
| FR (1) | FR2676444B1 (pt) |
| GR (1) | GR3015389T3 (pt) |
| HU (2) | HUT61305A (pt) |
| IE (1) | IE66926B1 (pt) |
| IL (1) | IL101885A (pt) |
| MX (1) | MX9202282A (pt) |
| NO (1) | NO180233C (pt) |
| NZ (1) | NZ242760A (pt) |
| RU (1) | RU2088577C1 (pt) |
| TW (1) | TW227997B (pt) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5656631A (en) * | 1989-02-07 | 1997-08-12 | Sanofi | Pyridazine derivatives |
| US5461053A (en) * | 1989-02-07 | 1995-10-24 | Sanofi | Pyridazine derivatives |
| JP2983141B2 (ja) * | 1993-10-06 | 1999-11-29 | 株式会社三和化学研究所 | 新規化合物及び該化合物を有効成分とする脳機能改善剤 |
| GB9707693D0 (en) * | 1997-04-16 | 1997-06-04 | Smithkline Beecham Plc | Novel method of treatment |
| US6528529B1 (en) | 1998-03-31 | 2003-03-04 | Acadia Pharmaceuticals Inc. | Compounds with activity on muscarinic receptors |
| MXPA02011631A (es) * | 2000-05-26 | 2003-03-27 | Pfizer | Derivados de tropano utiles en terapia. |
| AR038957A1 (es) | 2001-08-15 | 2005-02-02 | Pharmacia Corp | Terapia de combinacion para el tratamiento del cancer |
| US8265724B2 (en) * | 2007-03-09 | 2012-09-11 | Nellcor Puritan Bennett Llc | Cancellation of light shunting |
| AR081626A1 (es) | 2010-04-23 | 2012-10-10 | Cytokinetics Inc | Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos |
| AR081331A1 (es) | 2010-04-23 | 2012-08-08 | Cytokinetics Inc | Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos |
| WO2011133920A1 (en) | 2010-04-23 | 2011-10-27 | Cytokinetics, Inc. | Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use |
| CN111499615B (zh) * | 2017-08-04 | 2024-02-02 | 斯基霍克疗法公司 | 用于调节剪接的方法和组合物 |
| WO2019152809A1 (en) * | 2018-02-02 | 2019-08-08 | Vanderbilt University | Antagonists of the muscarinic acetylcholine receptor m4 |
| CN118812532A (zh) | 2019-02-05 | 2024-10-22 | 斯基霍克疗法公司 | 用于调节剪接的方法和组合物 |
| JP2022519311A (ja) * | 2019-02-05 | 2022-03-22 | スカイホーク・セラピューティクス・インコーポレーテッド | スプライシングを調節するための方法および組成物 |
| KR20210123344A (ko) * | 2019-02-05 | 2021-10-13 | 스카이호크 테라퓨틱스, 인코포레이티드 | 스플라이싱을 조절하는 방법 및 조성물 |
| CN113677342A (zh) * | 2019-02-05 | 2021-11-19 | 斯基霍克疗法公司 | 用于调节剪接的方法和组合物 |
| KR20210135507A (ko) | 2019-02-06 | 2021-11-15 | 스카이호크 테라퓨틱스, 인코포레이티드 | 스플라이싱을 조절하는 방법 및 조성물 |
| AR119731A1 (es) | 2019-05-17 | 2022-01-05 | Novartis Ag | Inhibidores del inflamasoma nlrp3 |
| US11129829B2 (en) | 2019-06-17 | 2021-09-28 | Skyhawk Therapeutics, Inc. | Methods for modulating splicing |
| WO2022166890A1 (zh) * | 2021-02-08 | 2022-08-11 | 南京明德新药研发有限公司 | 取代的哒嗪苯酚类衍生物 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2510998B1 (fr) * | 1981-08-07 | 1986-01-10 | Sanofi Sa | Nouveaux derives amines de la pyridazine, leur procede de preparation et les medicaments, a action desinhibitrice, qui en comportent |
| FR2539741A1 (fr) * | 1983-01-21 | 1984-07-27 | Sanofi Sa | Composes a noyau heterocyclique diazote, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent |
| FR2540113A1 (fr) * | 1983-01-27 | 1984-08-03 | Sanofi Sa | Acides derives de la pyridazine actifs sur le systeme nerveux central |
| FR2665442B1 (fr) * | 1990-07-31 | 1992-12-04 | Sanofi Sa | Derives d'alkyl-6 pyridazine, procede de preparation et compositions pharmaceutiques en contenant. |
| FR2642648B1 (fr) * | 1989-02-07 | 1991-06-21 | Sanofi Sa | Utilisation de derives d'alkyl-5 pyridazine comme medicaments actifs sur le systeme cholinergique |
| FR2663326B2 (fr) * | 1989-11-17 | 1992-10-16 | Sanofi Sa | Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant. |
| PT93060B (pt) * | 1989-02-07 | 1995-12-29 | Sanofi Sa | Processo para a obtencao de derivados de piridazina e de composicoes farmaceuticas que os contem |
| GB8911158D0 (en) * | 1989-05-16 | 1989-07-05 | Janssen Pharmaceutica Nv | Antiviral pyridazinamines |
-
1991
- 1991-05-16 FR FR9105973A patent/FR2676444B1/fr not_active Expired - Lifetime
-
1992
- 1992-05-12 TW TW081103670A patent/TW227997B/zh active
- 1992-05-15 BR BR929201854A patent/BR9201854A/pt not_active Application Discontinuation
- 1992-05-15 ES ES92401333T patent/ES2065755T3/es not_active Expired - Lifetime
- 1992-05-15 HU HU9201626A patent/HUT61305A/hu unknown
- 1992-05-15 DK DK92401333.7T patent/DK0514277T3/da active
- 1992-05-15 MX MX9202282A patent/MX9202282A/es unknown
- 1992-05-15 NZ NZ242760A patent/NZ242760A/en unknown
- 1992-05-15 AU AU16274/92A patent/AU656770B2/en not_active Ceased
- 1992-05-15 IL IL10188592A patent/IL101885A/en not_active IP Right Cessation
- 1992-05-15 CZ CS921473A patent/CZ282531B6/cs unknown
- 1992-05-15 EP EP92401333A patent/EP0514277B1/fr not_active Expired - Lifetime
- 1992-05-15 NO NO921949A patent/NO180233C/no unknown
- 1992-05-15 AT AT92401333T patent/ATE115569T1/de not_active IP Right Cessation
- 1992-05-15 US US07/883,168 patent/US5276036A/en not_active Expired - Fee Related
- 1992-05-15 FI FI922235A patent/FI922235A/fi unknown
- 1992-05-15 CA CA002068770A patent/CA2068770A1/en not_active Abandoned
- 1992-05-15 RU SU925011796A patent/RU2088577C1/ru active
- 1992-05-15 DE DE69200895T patent/DE69200895T2/de not_active Expired - Fee Related
- 1992-05-16 KR KR1019920008304A patent/KR920021517A/ko not_active Application Discontinuation
- 1992-05-18 JP JP4124981A patent/JPH0673021A/ja not_active Withdrawn
- 1992-07-01 IE IE921557A patent/IE66926B1/en not_active IP Right Cessation
-
1995
- 1995-03-13 GR GR950400542T patent/GR3015389T3/el unknown
- 1995-06-29 HU HU95P/P00577P patent/HU211920A9/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU9201626D0 (en) | 1992-08-28 |
| CA2068770A1 (en) | 1992-11-17 |
| DE69200895T2 (de) | 1995-06-29 |
| DE69200895D1 (de) | 1995-01-26 |
| NO921949D0 (no) | 1992-05-15 |
| AU656770B2 (en) | 1995-02-16 |
| FR2676444A1 (fr) | 1992-11-20 |
| CZ147392A3 (en) | 1993-03-17 |
| CZ282531B6 (cs) | 1997-08-13 |
| EP0514277B1 (fr) | 1994-12-14 |
| ES2065755T3 (es) | 1995-02-16 |
| KR920021517A (ko) | 1992-12-18 |
| NO921949L (no) | 1992-11-17 |
| IE66926B1 (en) | 1996-02-07 |
| HU211920A9 (en) | 1996-01-29 |
| FR2676444B1 (fr) | 1995-03-10 |
| GR3015389T3 (en) | 1995-06-30 |
| NO180233B (no) | 1996-12-02 |
| MX9202282A (es) | 1992-12-01 |
| FI922235A0 (fi) | 1992-05-15 |
| DK0514277T3 (da) | 1995-05-01 |
| IE921557A1 (en) | 1992-11-18 |
| HUT61305A (en) | 1992-12-28 |
| NZ242760A (en) | 1994-12-22 |
| BR9201854A (pt) | 1993-01-05 |
| TW227997B (pt) | 1994-08-11 |
| EP0514277A1 (fr) | 1992-11-19 |
| IL101885A0 (en) | 1992-12-30 |
| IL101885A (en) | 1996-08-04 |
| RU2088577C1 (ru) | 1997-08-27 |
| ATE115569T1 (de) | 1994-12-15 |
| US5276036A (en) | 1994-01-04 |
| AU1627492A (en) | 1992-11-19 |
| FI922235A (fi) | 1992-11-17 |
| JPH0673021A (ja) | 1994-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO180233C (no) | Derivater av 3-aminopyridaziner som virker på sentralnervesystemet, samt farmasöytiske preparater som inneholder dem | |
| AR038433A2 (es) | Derivados 2-alquil-2-desoxo de parahercuamida y marcfortina | |
| NO933482L (no) | N-sulfonyl-2-oksoindol-derivater som har affinitet for vasopressin- og/eller ocytocin-reseptorer | |
| EP1043324A4 (en) | PURINE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THEM AS AN ACTIVE INGREDIENT | |
| CA2311742A1 (en) | 6-amino-9-benzyl-8-hydroxypurine derivatives | |
| FI933273A0 (fi) | Polyvinylaminderivat med hydrofila centra, foerfarande foer deras framstaellning samt anvaendning av foereningarna som laekemedel, baerare foer aktivt aemne och hjaelpmedel foer naeringsaemnen | |
| DK0499521T3 (da) | Hidtil ukendte N-myristoyltransferaseinhibitorer, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
| NO942952D0 (no) | 11-benzaldoksin-17 ater, fremgangsmåte for deres fremstilling samt legemiddel inneholdende slike | |
| ES2126370T3 (es) | Nuevos derivados de n,n'-di(aralquil)-n,n'-di(2-azaaralquil)alquilenodiamina y su utilizacion en unas composiciones farmaceuticas y cosmeticas. | |
| BR0110211A (pt) | Derivados de oxadiazol tendo efeitos anticâncer | |
| ES2098023T3 (es) | Compuestos de estructura guanidinica y composiciones farmaceuticas que los contienen. | |
| DK0488897T3 (da) | Guanidinderivater, fremgangsmåde til fremstilling heraf samt farmaceutiske midler indeholdende disse | |
| MX9203360A (es) | Derivados de hexahidroazepinas y composiciones farmaceuticas que los contienen. | |
| NO921159L (no) | Tiazolidinon- og oksazolidinonderivater, fremgangsmaate til fremstilling derav, samt anvendelse av derivatene som vasodilatorer | |
| KR920701240A (ko) | 글루타티온 유도체 | |
| NO980531D0 (no) | Medikament for hemming av avhengighets og toleranse utviklet som fölge av et narkotisk smertestillende middel | |
| DK0571243T3 (da) | Thiochromanderivater, fremgangsmåder til fremstilling heraf samt farmaceutiske midler indeholdende d isse | |
| DK0486385T3 (da) | Imidazolderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
| ES2140524T3 (es) | Derivados de metotrexato. | |
| DK0466662T3 (da) | 6,7-Disubstituerede-2-aminotetraliner, der er aktive som immunmodulatorer, samt farmaceutiske præparater indeholdende sådanne forbindelser | |
| BR9815448A (pt) | Derivados de imino-aza-antraciclinona para o tratamento de amiloidose | |
| ES2111768T3 (es) | Derivados de carboestirilo utilizados como agentes antiarritmicos. | |
| MX9203929A (es) | Derivados de 1,2,4-tiadiazino[3,4-b]benzotiazol, procedimiento para su preparacion y medicamentos que los contienen. | |
| AR001786A1 (es) | Composición farmacéutica para tratar y prevenir enfermedades mediante la regulación de apoptosis | |
| ES2192827T3 (es) | Derivados de 8h-(2,3-b)-pirrolicin-8-ona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. |